Avioq, Inc. products

The Avioq HIV-1 Microelisa System is intended for use as an aid in diagnosis of infection with HIV-1. It is not intended for use in screening blood donors.   Developed as a standard two-step indirect microelisa system assay, the Avioq HIV-1 Microelisa System contains coated 96-well microwell plates, color-coded, liquid calibrator and positive control, and a ready-to-use liquid substrate. The sample diluent contains sample addition monitoring to allow visualization of color change upon sample addition to microwells.

Serologic assay for detection and differentiation of antibodies directed to different gene products of HIV-1 and HIV-2

The Avioq HTLV-I/II Microelisa System is intended as a screen for donated blood and organs to prevent transmission of HTLV-I and HTLV-II to recipients of cellular blood components and as an aid in clinical diagnosis of HTLV-I or HTLV-II infection and related disease

Recombinant HIV-1 gp160 derived from HIV-1 clade C and expressed in HEK-293.

Recombinant HIV-1 p24 protein produced in E.coli Expression System.